Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Inventory Average (2016 - 2025)

Heron Therapeutics' Inventory Average history spans 10 years, with the latest figure at $81.4 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 64.23% year-over-year to $81.4 million; the TTM value through Dec 2025 reached $81.4 million, up 64.23%, while the annual FY2025 figure was $73.0 million, 53.15% up from the prior year.
  • Inventory Average reached $81.4 million in Q4 2025 per HRTX's latest filing, up from $71.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $81.4 million in Q4 2025 to a low of $21.1 million in Q1 2024.
  • Average Inventory Average over 5 years is $49.5 million, with a median of $48.9 million recorded in 2023.
  • Peak YoY movement for Inventory Average: tumbled 60.42% in 2024, then surged 202.34% in 2025.
  • A 5-year view of Inventory Average shows it stood at $44.9 million in 2021, then rose by 18.83% to $53.4 million in 2022, then dropped by 21.25% to $42.1 million in 2023, then increased by 17.82% to $49.6 million in 2024, then soared by 64.23% to $81.4 million in 2025.
  • Per Business Quant, the three most recent readings for HRTX's Inventory Average are $81.4 million (Q4 2025), $71.5 million (Q3 2025), and $64.9 million (Q2 2025).